Michael Shpigelmacher, Founder and CEO of Bionaut Labs, with the company’s micro-robot designed to swim through the central nervous system into the brain to treat disease now on trial in the U.S.PrimeSense, the previous company founded by Michael Shpigelmacher, Aviad Maizels and Alex Shpunt, was acquired in 2013 by Apple AAPL for around $400 million.

Bionaut实验室创始人兼首席执行官迈克尔·希皮格尔马赫（MichaelShpigelmacher）设计了该公司的微型机器人，该机器人旨在通过中枢神经系统进入大脑治疗疾病，目前正在美国PrimeSense进行试验。由迈克尔·希皮格尔马赫（MichaelShpigelmacher）、阿维德·梅泽尔斯（AviadMaizels）和亚历克斯·希普特（AlexShpunt）创建的前一家公司于2013年被苹果AAPL以约4亿美元收购。

It was a world leader in 3D sensors that helped power the Microsoft MSFT Kinect for Xbox 360 and provided the technology behind Apple’s Face ID.Bionaut Labs, the medical startup founded by the trio, is on a very different journey – into the deepest recesses of the human brain. But the company is already making waves.

它是3D传感器领域的世界领先者，为微软MSFT Kinect为Xbox 360提供了动力，并提供了苹果面部ID背后的技术。由三人组成的医疗初创公司Bionaut Labs正走在一条截然不同的道路上——进入人类大脑的最深处。但该公司已经在掀起波澜。

This month, Bill Gates’ Gates Ventures joined its early funders, extending investment to $70 million from a blue-chip roster including the Mayo Clinic, Khosla Ventures, Upfront Ventures and OurCrowd, Fortune magazine reported.The company’s Bionaut, a tiny micro-robot smaller than a grain of rice, is guided through a patient’s central nervous system into a targeted spot in the brain where it can perform minor surgery, deliver therapeutic drugs or return with tissue for a biopsy. Not since Raquel Welch was shrunk and inserted into a patient’s bloodstream in the 1966 movie “Fantastic Voyage” have doctors come so close to targeting life-saving medication so precisely to reach the inaccessible recesses of the human body. The company is testing its technology at a Mayo Clinic facility and is poised to begin clinical trials with five top-tier U.S.

据《财富》杂志报道，本月，比尔·盖茨（BillGates）旗下的盖茨风险投资公司（Gates Ventures）加入了早期资助者的行列，从包括梅奥诊所（Mayo Clinic）、科斯拉风险投资公司（Khosla Ventures）、前期风险投资公司（Upfront Ventures）和我们的人群（OurCrowd）在内的蓝筹。该公司的Bionaut是一种比一粒米还小的微型机器人，它被引导通过患者的中枢神经系统进入大脑的目标部位，在那里它可以进行小手术，输送治疗药物或带回组织进行活检。自从1966年的电影《梦幻之旅》中拉奎尔·韦尔奇（RaquelWelch）被缩小并插入患者的血液中以来，医生们从未如此接近于将救生药物精确地定位到人体无法接近的深处。该公司正在梅奥诊所测试其技术，并准备与五家顶级美国公司开始临床试验。

medical centers as it applies for FDA approval. Investors can still join the Bionaut Labs funding round via the OurCrowd investment platform.Shpigelmacher, CEO of Bionaut Labs, says he realized that treatments for disease occurring at a specific point in the body – especiall.

申请FDA批准的医疗中心。投资者仍然可以通过OurCrowd投资平台加入Bionaut实验室的融资回合。Bionaut实验室首席执行官Shpigelmacher说，他意识到治疗疾病发生在身体的特定部位，特别是。